Long-Term Impacts of the COVID-19 Pandemic on Drug/Alcohol Use Prevalence in a Population with Substance Use Disorders

Author:

Gili Alessio1ORCID,Lancia Massimo2,Gambelunghe Angela3ORCID,Tomassini Luca2ORCID,Nicoletti Alessia2,Aroni Kyriaki2ORCID,Gambelunghe Cristiana2ORCID

Affiliation:

1. Hygiene and Public Health Section, Department of Medicine and Surgery, University of Perugia, Piazza Lucio Severi, 06132 Perugia, Italy

2. Forensic Medicine, Forensic Science and Sports Medicine Section, Department of Medicine and Surgery, University of Perugia, Piazza Lucio Severi, 06132 Perugia, Italy

3. Occupational Medicine, Respiratory Diseases and Toxicology Section, Department of Medicine and Surgery, University of Perugia, Piazza Lucio Severi, 06132 Perugia, Italy

Abstract

As time passes, the long-term effects of the COVID-19 pandemic are becoming increasingly apparent. The extreme restrictions imposed during the pandemic have had detrimental impacts on the most vulnerable groups, such as individuals suffering from substance and/or alcohol disorders (SUDs). This study reports quarterly laboratory data on alcohol and drug use in 150 subjects with SUDs that were examined using hair analysis for 2 years before the start of pandemic until after the end of the Italian health emergency. Overall, it was found that the number of subjects who used heroin, cocaine, and MDMA all decreased during the 2020 and 2021 lockdowns, increasing during reopening and subsequently stabilizing close to pre-COVID levels. Cannabis use was less impacted, remaining stable throughout the pandemic. Alcohol and benzodiazepine use both increased significantly during the lockdowns, displaying an opposing trend. While benzodiazepine use progressively returned to baseline levels, alcohol remained at significantly increased levels, even in September 2022. Long-term heavy drinking combined with substance use should be seriously considered, since these results in several health and social problems alongside alcohol-related comorbidities. Thus, appropriate response plans should be implemented both during and after the pandemic, whilst focusing on those who are most vulnerable.

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health

Reference36 articles.

1. WHO (2020, November 06). Mental Health and Psychosocial Considerations during the COVID-19 Outbreak. Available online: moz-extension://5111151d-1a58-4193-9a09-0f93aabf3f57/enhanced-reader.html?openApp&pdf=https%3A%2F%2Fwww.who.int%2Fdocs%2Fdefault-source%2Fcoronaviruse%2Fmental-health-considerations.pdf.

2. (2020, November 05). Gazzetta Ufficiale Gazzetta Ufficiale. Available online: https://www.gazzettaufficiale.it/eli/id/2020/03/22/20A01807/sg.

3. (2023, February 22). Gazzetta Ufficiale. Available online: https://www.gazzettaufficiale.it/eli/id/2020/04/27/20A02352/sg.

4. (2023, February 22). Gazzetta Ufficiale. Available online: https://web.archive.org/web/20201030114745/https://www.gazzettaufficiale.it/eli/id/2020/10/25/20A05861/sg.

5. (2023, February 22). Gazzetta Ufficiale. Available online: https://www.gazzettaufficiale.it/eli/id/2020/11/04/20A06109/sg.

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3